Advancing point-of-care testing: Independent evaluation of the Truvian Platform

28 Aug 2024

Truvian’s Platform is a benchtop blood testing analyzer that can generate 34 test results, including a Chemistry Panel, Lipid Panel, HbA1c, TSH, and CBC in under 30 minutes with 300 µL whole blood from a single Lithium Heparin sample. This poster describes a study focused on the rigorous evaluation of the accuracy, reliability, and usability of Truvian's platform in a point-of-care clinical setting run by untrained operators.

Links

Tags

Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.
Advancing point-of-care testing: Independent evaluation of the Truvian Platform